Ledger.Open graph →

SEC Form D · filed October 24, 2014

MINERVA BIOTECHNOLOGIES Corp

Offering

$30.0M

Sold

$2.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WALTHAM, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Cynthia Bamdad · Waltham, MAExec · Director Kenneth Kosik · Waltham, MADirector Joseph A. Nathan · Waltham, MADirector James R. Bridges · Waltham, MADirector Normand F. Smith · Waltham, MAExec · Director Robert Staszewski · Waltham, MADirector Kenneth A. Reed · Waltham, MADirector James V. O'Donnell · Saint Louis, MODirector Brandon Jundt · Denver, COExec · Director Ronald E. Osman · Saint Louis, MOExec · Director Lowell J. Burnett · San Diego, CAExec · Director Brent Eley · Bellevue, WADirector Milton Pinsky · Northbrook, ILExec · Director Brad Sargent · Cupertino, CADirector Michael Cassara · San Diego, CADirector Benjamin Alfonsi · New York, NYDirector Michael Skead · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗